Cita APA (7a ed.)
Basu, S., Parghane, R. V., Suman, S., Joshi, A., Prabhash, K., Bakshi, G., & Banerjee, S. (2020). Towards personalizing treatment strategies in mCRPC: Can dual-tracer PET-CT provide insights into tumor biology, guide the optimal treatment sequence, and individualize decision-making (between chemotherapy, second-generation anti-androgens and PSMA-directed radioligand therapy) early in the disease course? European Journal of Nuclear Medicine & Molecular Imaging, 47(8), 1793-1798.
Cita Chicago Style (17a ed.)
Basu, Sandip, Rahul V. Parghane, Sonam Suman, Amit Joshi, Kumar Prabhash, Ganesh Bakshi, y Sharmila Banerjee. "Towards Personalizing Treatment Strategies in MCRPC: Can Dual-tracer PET-CT Provide Insights into Tumor Biology, Guide the Optimal Treatment Sequence, and Individualize Decision-making (between Chemotherapy, Second-generation Anti-androgens and PSMA-directed Radioligand Therapy) Early in the Disease Course?" European Journal of Nuclear Medicine & Molecular Imaging 47, no. 8 (2020): 1793-1798.
Cita MLA (9a ed.)
Basu, Sandip, et al. "Towards Personalizing Treatment Strategies in MCRPC: Can Dual-tracer PET-CT Provide Insights into Tumor Biology, Guide the Optimal Treatment Sequence, and Individualize Decision-making (between Chemotherapy, Second-generation Anti-androgens and PSMA-directed Radioligand Therapy) Early in the Disease Course?" European Journal of Nuclear Medicine & Molecular Imaging, vol. 47, no. 8, 2020, pp. 1793-1798.
Precaución: Estas citas no son 100% exactas.